Condition: Iron Deficiency Anemia · Pregnancy · Sponsor: Women and Infants Hospital of Rhode Island
Double blind, placebo controlled, multicenter randomized trial in pregnant women in the U.S. (N=300) to test the central hypothesis that IV iron in pregnant women with IDA (Hb\<11 g/dL and ferritin\<30 ng/mL) at 13 - 30 weeks will be effective, safe and cost-effective in reducing severe maternal morbidity-as measured by maternal anemia at delivery-and will also improve offspring neurodevelopment.
This description comes directly from the study's public registry record.
Crystal Ware, BSN, CCRP · 401-274-1122 · cware@wihri.org
Always discuss trial participation with your own doctor first.
| University of Alabama Medical Center | Birmingham, Alabama, United States | Recruiting |
| GNP Research at Heme-on-Call | Miami, Florida, United States | Recruiting |
| Michigan University Medical Center | Ann Arbor, Michigan, United States | Recruiting |
| Washington University Medical Center | St Louis, Missouri, United States | Recruiting |
| Oregon Health and Sciences Uiversity Medical Center | Portland, Oregon, United States | Recruiting |
| Hasbro Children's Hospital | Providence, Rhode Island, United States | Recruiting |
| Women & Infants Hospital of Rhode Island | Providence, Rhode Island, United States | Recruiting |
| University of Utah Hospital | Salt Lake City, Utah, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05462704